Economic evaluation of five first-line PD-(L)1 inhibitors for treating non-squamous non-small cell lung cancer in China: A cost-effectiveness analysis based on network meta-analysi...

por Chen, Xi, Zhao, Mingye, Tian, Lei
Publicado 2023

Traffic Flow Prediction and Analysis in Smart Cities Based on the WND-LSTM Model

por Ma, SuYuan, Zhao, MingYe
Publicado 2022

Cost-effectiveness analysis of sintilimab vs. placebo in combination with chemotherapy as first-line therapy for local advanced or metastatic oesophageal squamous cell carcinoma

por Shao, Taihang, Zhao, Mingye, Tang, Wenxi
Publicado 2022

Effectiveness and Cost-Effectiveness of Non-Pharmacological Interventions among Chinese Adults with Prediabetes: A Protocol for Network Meta-Analysis and CHIME-Modeled Cost-Effecti...

por Yin, Yue, Tu, Yusi, Zhao, Mingye, Tang, Wenxi
Publicado 2022

Cost-effectiveness analysis of camrelizumab plus chemotherapy as first-line treatment for advanced squamous NSCLC in China

por Shao, Taihang, Ren, Yinan, Zhao, Mingye, Tang, Wenxi
Publicado 2022

A systematic review and network meta-analysis of first-line immune checkpoint inhibitor combination therapies in patients with advanced non-squamous non-small cell lung cancer

por Shao, Taihang, Zhao, Mingye, Liang, Leyi, Tang, Wenxi
Publicado 2022

Effectiveness and cost-effectiveness analysis of 11 treatment paths, seven first-line and three second-line treatments for Chinese patients with advanced wild-type squamous non-sma...

por Zhao, Mingye, Shao, Taihang, Chi, Zhuoyuan, Tang, Wenxi
Publicado 2023

Impact of Extrapolation Model Choices on the Structural Uncertainty in Economic Evaluations for Cancer Immunotherapy: A Case Study of Checkmate 067

por Shao, Taihang, Zhao, Mingye, Liang, Leyi, Shi, Lizheng, Tang, Wenxi
Publicado 2023

Cost-effectiveness and potential budget impact of non-pharmacological interventions for early management in prehypertensive people: an economic evaluation for China

por Liang, Leyi, Shao, Taihang, Li, Hao, Zhao, Mingye, Tang, Wenxi
Publicado 2023

Economic Evaluation of Nemonoxacin, Moxifloxacin and Levofloxacin in the Treatment of Early Community-Acquired Pneumonia with Possible Pulmonary Tuberculosis

por Zhao, Mingye, Chi, Zhuoyuan, Pan, Xingming, Yin, Yue, Tang, Wenxi
Publicado 2022

The hemodynamic stability of remimazolam compared with propofol in patients undergoing endoscopic submucosal dissection: A randomized trial

por Qiu, Yuwei, Gu, Wei, Zhao, Mingye, Zhang, Yunyun, Wu, Jingxiang
Publicado 2022

Adverse outcomes of artificial pneumothorax under right bronchial occlusion for patients with thoracoscopic-assisted oesophagectomy in the prone position versus the semiprone posit...

por Li, Qiongzhen, Zhao, Mingye, Wu, Dongjin, Guo, Xufeng, Wu, Jingxiang
Publicado 2022

Identifying optimal PD-1/PD-L1 inhibitors in first-line treatment of patients with advanced squamous non-small cell lung cancer in China: Updated systematic review and network meta...

por Zhao, Mingye, Shao, Taihang, Ren, Yinan, Zhou, Caicun, Tang, Wenxi
Publicado 2022

Cost-effectiveness analysis of atezolizumab in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen: a United Kingdom health care pe...

por Jiang, Yunlin, Zhao, Mingye, Xi, Jiayi, Li, Jiaqi, Tang, Wenxi, Zheng, Xueping
Publicado 2023

Cost-effectiveness analysis of colonoscopy and fecal immunochemical testing for colorectal cancer screening in China

por Ren, Yinan, Zhao, Mingye, Zhou, Dachuang, Xing, Qian, Gong, Fangfang, Tang, Wenxi
Publicado 2022

Cost-Effectiveness Analysis of Five Systemic Treatments for Unresectable Hepatocellular Carcinoma in China: An Economic Evaluation Based on Network Meta-Analysis

por Zhao, Mingye, Pan, Xingming, Yin, Yue, Hu, Hongfei, Wei, Jifu, Bai, Zhaoshi, Tang, Wenxi
Publicado 2022

Hypoxemia in thoracoscopic lung resection surgery using a video double-lumen tube versus a conventional double-lumen tube: A propensity score-matched analysis

por Wang, Wei, Gong, Zhihao, Zhao, Mingye, Zhang, Zuojing, Qiu, Yuwei, Jiang, Qiliang, Wu, Jingxiang
Publicado 2023

Estimating the cost-effectiveness threshold of advanced non-small cell lung cancer in China using mean opportunity cost and contingent valuation method

por Peng, Qian, Yin, Yue, Liang, Min, Zhao, Mingye, Shao, Taihang, Tang, Yaqian, Mei, Zhiqing, Li, Hao, Tang, Wenxi
Publicado 2023